PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Biohaven Pharma (BHVN) CEO Buys Another $400K in Stock
November 1, 2022 8:19 AM EDTBiohaven Pharma (NYSE: BHVN) CEO, Vlad Coric, bought 25,800 shares on 10/31/22 at $15.968.
The value of the purchase was $411,995.
Yesterday, Coric disclosed the purchase of $2.1 million in stock.
... MorePfizer (PFE) Tops Q3 EPS by 34, Beats on Revenue; Offers FY Guidance
November 1, 2022 6:47 AM EDTPfizer (NYSE: PFE) reported Q3 EPS of $1.78, $0.34 better than the analyst estimate of $1.44. Revenue for the quarter came in at $22.6 billion versus the consensus estimate of $21.33 billion.
GUIDANCE:
Pfizer sees FY2022 EPS of $6.30-$6.45, versus the consensus of $6.38. Pfizer sees... More
